Last reviewed: May 1, 2026
Free Guide · Blue Goat Cyber · Updated 2026
CHECKLIST · 1 PAGE · PROSPECT RESOURCE
MSA Redlines: Usually Accepted vs. Not Streamline the final 10% of the contracting process.
Legal reviews of cybersecurity MSAs frequently stall on clauses that are non-standard for specialist MedTech consultancies. This checklist separates the redlines that almost always land from the ones that almost never do.
Procurement & liability norms Limitation of liability set to a multiple of contract value? (Standard) Unlimited liability for general negligence? (Non-negotiable) Insurance requirements aligned with industry-standard professional and cyber liability? (Standard) Most-Favoured-Nation pricing clauses? (Usually rejected)
IP & regulatory deliverables All work product for the FDA submission assigned to the client? (Standard) Client ownership of the consultant's proprietary scanning methodologies? (Rejected) Record retention clause sized for FDA audit support? (Standard) Specific language for SBOM and VEX confidentiality? (Required)
Speed-to-signature drivers Has the MSA been shared with legal before the final quote? (Recommended) Is a Mutual NDA already in place to cover the redline phase? (Required) Are you using a third-party procurement platform for the review? (Standard)
How to read it. More than two redlines from the 'Non-negotiable' or 'Rejected' rows usually means a brief alignment call between operations leads will save a contracting cycle.
NEXT STEP → Request our standard redline-response document to share with your legal team before the next review pass. Book your discovery call: go.bluegoatcyber.com/meetings/blue-goat-cyber/discovery-session
Page 1 · © Blue Goat Cyber · 250+ FDA submissions, zero rejections, since 2014
Talk to us
This guide is part of Blue Goat Cyber's MedTech cybersecurity library. To apply it to your device program, book a 30-minute strategy session - no cost, no obligation. Or browse all guides.
